Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma
- PMID: 35294862
- DOI: 10.1016/j.cmet.2022.02.011
Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma
Abstract
Extracellular vesicles (EVs) including exosomes act as intercellular communicators by transferring protein and microRNA cargoes, yet the role of EV lipids remains unclear. Here, we show that the pro-tumorigenic action of lymphoma-derived EVs is augmented via secreted phospholipase A2 (sPLA2)-driven lipid metabolism. Hydrolysis of EV phospholipids by group X sPLA2, which was induced in macrophages of Epstein-Barr virus (EBV) lymphoma, increased the production of fatty acids, lysophospholipids, and their metabolites. sPLA2-treated EVs were smaller and self-aggregated, showed better uptake, and increased cytokine expression and lipid mediator signaling in tumor-associated macrophages. Pharmacological inhibition of endogenous sPLA2 suppressed lymphoma growth in EBV-infected humanized mice, while treatment with sPLA2-modified EVs reversed this phenotype. Furthermore, sPLA2 expression in human large B cell lymphomas inversely correlated with patient survival. Overall, the sPLA2-mediated EV modification promotes tumor development, highlighting a non-canonical mechanistic action of EVs as an extracellular hydrolytic platform of sPLA2.
Keywords: EBV Lymphoma; extracellular vesicle; lipid mediator; sPLA₂.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment in
-
Making a sPLAsh: The expanding repertoire of EV signaling.Cell Metab. 2022 Apr 5;34(4):508-510. doi: 10.1016/j.cmet.2022.03.004. Cell Metab. 2022. PMID: 35385702
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
